Found 9 matching trials
480 STUDY: Phase 2b Study of Locteron Plus Ribavirin to Treat Hepatitis C Virus (HCV) PHASE2 The purpose of this 12-week study was to assess in subjects with chronic he...
Show More Learn More & Join Trial
Efficacy of PegetronŽ Redipen⢠Treatment and Treatment Compliance of Patients With Chronic Hepatitis C in Canada (P04423) N/A Treatment compliance is a key success factor in obtaining the full benefit ...
Show More Location
Multiple Locations
Learn More & Join Trial
Phase 2B Dose Ranging Study of Locteron Plus Ribavirin to Treat HCV PHASE2 The purpose of the study was to assess in subjects with chronic hepatitis C...
Show More Learn More & Join Trial
Evaluating Fine Needle Aspiration to Measure Hepatic Vaniprevir (MK-7009) Concentrations in Participants With Chronic Hepatitis C (MK-7009-048) PHASE1 This study will evaluate the technical feasibility of using fine needle asp...
Show More Location
Multiple Locations
Learn More & Join Trial
Safety and Efficacy Study to Compare Continuous Infusion of Interferon With Standard of Care for Chronic Hepatitis C PHASE2 The purpose of the study is to evaluate if continuous subcutaneous delivery...
Show More Location
Duke Clinical Research Institute
Learn More & Join Trial
Pegylated Interferon and Ribavirin Therapy in Chronic Hepatitis Genotype 4 PHASE4 Genotype 4 is the least-studied hepatitis C virus genotype and was consider...
Show More Location
AUS Specialized Hospital,
Learn More & Join Trial
A Study of the Safety and Efficacy of Pegylated Inferferon Alfa-2b (PEG-Intronâ˘) Versus Pegylated Interferon Alfa-2a (PEGASYSâ˘) in Participants With Chronic Hepatitis B (P08450) PHASE3 This study is being done to compare the safety and efficacy of PEG-Intron⢠...
Show More Location
Multiple Locations
Learn More & Join Trial
A Study of Different Doses of Grazoprevir (MK-5172) Given With Pegylated Interferon Alfa-2b and Ribavirin to Treatment-NaĂŻve Participants With Chronic Hepatitis C (MK-5172-038) PHASE2 This is a study designed to compare the safety and efficacy of 3 different ...
Show More Location
Multiple Locations
Learn More & Join Trial
Gefitinib and PEG-Interferon Alfa-2b in Treating Patients With Unresectable or Metastatic Kidney Cancer PHASE2 RATIONALE: Gefitinib may stop the growth of kidney cancer by blocking blood...
Show More Location
City of Hope Comprehensive Cancer Center
Learn More & Join Trial